Abstract
The measurement of lecithin: cholesterol acyltransferase (LCAT, EC 2.3.1.43) activity is important in high-density lipoprotein (HDL) metabolism study and cardiovascular disease (CVD) risk assessment. However, current methods suffer from complex design and preparation of exogenous substrate, low reproducibility, and interference of cofactors. In this study, we developed a simple and precise high performance liquid chromatography (HPLC) method for the measurement of LCAT activity. By using 7-dehydrocholesterol (7-DHC) and 1,2-didecanoyl-sn-glycero-3-phosphocholine(10:0PC) as substrates, and an LCAT activating peptide (P642) as activator and emulsifier, the substrate reagent was easily made by vortex. The substrate reagent was mixed with serum samples (50:1, v/v) and incubated at 37 °C for 1 h. After incubation, the lipid was extracted with hexane and ethanol. With a conjugated double bond and ultraviolet absorption, 7-DHC and its esterification product could be separated and analyzed by a single HPLC run without calibration. LCAT activity was a linear function of the serum sample volume and the intra- and total assay coefficients of variation (CV) less than 2.5% were obtained under the standardized conditions. The substrate reagent was stable, and assay result accurately reflected LCAT activity. LCAT activities in 120 healthy subjects were positively correlated with triglyceride (P < 0.05), fractional esterification rate of HDL cholesterol (FERHDL) (P < 0.0001), and negatively correlated with apolipoprotein AI (apoAI) (P < 0.05) and HDL cholesterol (HDL-C) (P < 0.001). These results suggest that this method is sensitive, reproducible, and not greatly influenced by serum components and added substances, and will be a useful tool in the lipid metabolism study and the risk assessment of CVD.
Similar content being viewed by others
Abbreviations
- CER:
-
Cholesterol esterification rate
- CVD:
-
Cardiovascular diseases
- FC:
-
Free cholesterol
- FERHDL :
-
Fractional esterification rate of HDL cholesterol
- HDL:
-
High-density lipoprotein
- HDL-C:
-
HDL cholesterol
- LCAT:
-
Lecithin/cholesterol acyltransferase
- PC:
-
Phosphatidylcholine
- P642:
-
LCAT-activating peptide
- RCT:
-
Reverse cholesterol transport
- 7-DHC:
-
7-Dehydrocholesterol
References
Toth PP, Barter PJ, Rosenson RS, Boden WE, Chapman MJ, Cuchel M, et al. High-density lipoproteins: a consensus statement from the National Lipid Association. J Clin Lipidol. 2013;7(5):484–525.
Scarpioni R, Paties C, Bergonzi G. Dramatic atherosclerotic vascular burden in a patient with familial lecithin-cholesterol acyltransferase (LCAT) deficiency. Nephrol Dial Transplant. 2008;23(3):1074. author reply 1074-1075
Kuivenhoven JA, van Voorst tot Voorst EJ, Wiebusch H, Marcovina SM, Funke H, Assmann G, et al. A unique genetic and biochemical presentation of fish-eye disease. J Clin Invest. 1995;96(6):2783–91.
Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med. 2012;367(22):2089–99.
Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365(24):2255–67.
Sethi AA, Sampson M, Warnick R, Muniz N, Vaisman B, Nordestgaard BG, et al. High pre-beta1 HDL concentrations and low lecithin:cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol. Clin Chem. 2010;56(7):1128–37.
Dullaart RP, Tietge UJ, Kwakernaak AJ, Dikkeschei BD, Perton F, Tio RA. Alterations in plasma lecithin:cholesterol acyltransferase and myeloperoxidase in acute myocardial infarction: implications for cardiac outcome. Atherosclerosis. 2014;234(1):185–92.
Dullaart RP, Perton F, van der Klauw MM, Hillege HL, Sluiter WJ. High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol. Atherosclerosis. 2010;208(2):537–42.
Dullaart RP, Perton F, Sluiter WJ, de Vries R, van Tol A. Plasma lecithin:cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness. J Clin Endocrinol Metab. 2008;93(12):4860–6.
Tanaka S, Yasuda T, Ishida T, Fujioka Y, Tsujino T, Miki T, et al. Increased serum cholesterol esterification rates predict coronary heart disease and sudden death in a general population. Arterioscler Thromb Vasc Biol. 2013;33(5):1098–104.
Calabresi L, Baldassarre D, Simonelli S, Gomaraschi M, Amato M, Castelnuovo S, et al. Plasma lecithin:cholesterol acyltransferase and carotid intima-media thickness in European individuals at high cardiovascular risk. J Lipid Res. 2011;52(8):1569–74.
Holleboom AG, Kuivenhoven JA, Vergeer M, Hovingh GK, van Miert JN, Wareham NJ, et al. Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study. J Lipid Res. 2010;51(2):416–21.
Marcel YL, Vezina C. A method for the determination of the initial rate of reaction of lecithin:cholesterol acyltransferase in human plasma. Biochim Biophys Acta. 1973;306(3):497–504.
Dobiasova M, Adler L, Ohta T, Frohlich J. Effect of labeling of plasma lipoproteins with [(3)H]cholesterol on values of esterification rate of cholesterol in apolipoprotein B-depleted plasma. J Lipid Res. 2000;41(8):1356–7.
Dong J, Yu S, Yang R, Li H, Guo H, Zhao H, et al. A simple and precise method for direct measurement of fractional esterification rate of high density lipoprotein cholesterol by high performance liquid chromatography. Clin Chem Lab Med. 2014;52(4):557–64.
Frohlich J, Dobiasova M. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem. 2003;49(11):1873–80.
Chen CH, Albers JJ. Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin:cholesterol acyltransferase activity. J Lipid Res. 1982;23(5):680–91.
Manabe M, Abe T, Nozawa M, Maki A, Hirata M, Itakura H. New substrate for determination of serum lecithin:cholesterol acyltransferase. J Lipid Res. 1987;28(10):1206–15.
Vaisman BL, Remaley AT. Measurement of lecithin-cholesterol acyltransferase activity with the use of a peptide-proteoliposome substrate. Methods Mol Biol. 2013;1027:343–52.
Fielding CJ, Shore VG, Fielding PE. Lecithin:cholesterol acyltransferase: effects of substrate composition upon enzyme activity. Biochim Biophys Acta. 1972;270(4):513–8.
Homan R, Esmaeil N, Mendelsohn L, Kato GJ. A fluorescence method to detect and quantitate sterol esterification by lecithin:cholesterol acyltransferase. Anal Biochem. 2013;441(1):80–6.
Piran U, Nishida T. Utilization of various sterols by lecithin-cholesterol acyltransferase as acyl acceptors. Lipids. 1979;14(5):478–82.
Bartholome M, Niedmann D, Wieland H, Seidel D. An optimized method for measuring lecithin:cholesterol acyltransferase activity, independent of the concentration and quality of the physiological substrate. Biochim Biophys Acta. 1981;664(2):327–34.
Dobiasova M, Frohlich J, Sedova M, Cheung MC, Brown BG. Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. J Lipid Res. 2011;52(3):566–71.
Liu J, Yang R, Zhou M, Mao W, Li H, Zhao H, et al. Fractional esterification rate of cholesterol in high-density lipoprotein associates with risk of coronary heart disease. Lipids Health Dis. 2017;16(1):162.
Albers JJ, Chen CH, Adolphson JL. Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate. J Lipid Res. 1981;22(8):1206–13.
Tani S, Takahashi A, Nagao K, Hirayama A. Association of lecithin–cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional study. Heart Vessel. 2015;31(6):831–40.
Hovig T, Gjone E. Familial plasma lecithin:cholesterol acyltransferase (LCAT) deficiency. Ultrastructural aspects of a new syndrome with particular reference to lesions in the kidneys and the spleen. Acta Pathol Microbiol Scand A Pathol. 1973;81(5):681–97.
Wells IC, Peitzmeier G, Vincent JK. Lecithin:cholesterol acyltransferase and lysolecithin in coronary atherosclerosis. Exp Mol Pathol. 1986;45(3):303–10.
Kobori K, Saito K, Ito S, Kotani K, Manabe M, Kanno T. A new enzyme-linked immunosorbent assay with two monoclonal antibodies to specific epitopes measures human lecithin-cholesterol acyltransferase. J Lipid Res. 2002;43(2):325–34.
Acknowledgments
This study was supported by research grants from the National Natural Science Foundation of China (81472035, 81171647, 81501842).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was reviewed and approved by the Beijing Hospital Ethics Committee. All studied individuals were informed in writing of the intended use of their samples and each provided written consent.
Conflict of interest
No authors declared any potential conflicts of interest. The funding organizations played no role in the design of the study, review and interpretation of data, or preparation or approval of the manuscript.
Electronic supplementary material
ESM 1
(PDF 506 kb).
Rights and permissions
About this article
Cite this article
Wang, Y., Wang, S., Zhang, L. et al. A simple and precise method to detect sterol esterification activity of lecithin/cholesterol acyltransferase by high-performance liquid chromatography. Anal Bioanal Chem 410, 1785–1792 (2018). https://doi.org/10.1007/s00216-017-0834-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-017-0834-4